Ann: Operational Update, page-53

Margaret your post about Suda being pushed around is an interesting one and you briefly allude to one thing that has concerned me for some time.

In my discussions with the Company I have been assured many times we had competitive pressure on our products yet the reality of what has unfolded over the past few years would suggest that simply isn't the case.

It is that which will get Pharma to act and pay up - no competitive presure and they will string it out.

Why so few co-development deals for those who want their drug in a spray form?

Way too many questions currently and it is my view that Paul will have to clarify our operations so the market understands what we do. I take a very close interest and I really have little idea where we are at, so what chance has any new investor got.

Suda is a tightly wound spring currently and we need someone to release it rather than tether it down further.
In the end Margaret nothing will happen to our share price until Suda come to grips with their communication because even a half decent deal will be delivered with a decent dose of ambiguity and questions.

Clyde